ETF涨跌幅排行丨光伏、中药相关ETF涨幅居前

Group 1 - The A-share market experienced a collective decline on August 1, with the Shanghai Composite Index down by 0.37%, the Shenzhen Component down by 0.17%, and the ChiNext Index down by 0.24% [1] - The pharmaceutical sector showed resilience, with all stocks in this sector rising against the market trend, while the sports concept sector underwent a collective adjustment [1] - ETFs related to photovoltaic and traditional Chinese medicine saw significant gains, with the Hang Seng Consumption ETF (159699) leading with a rise of 4.69% and a turnover rate of 10.28% [2] Group 2 - The implementation of the "Regulations on the Labeling of Traditional Chinese Medicine Pieces" on August 1 mandates detailed labeling, including shelf life and origin, which is expected to enhance industry standardization and accelerate the exit of small enterprises, thereby boosting confidence in leading pharmaceutical companies [2] - A report from Huatai Securities indicated that the National Engineering Laboratory for the Preparation of Polysilicon Materials is revising the comprehensive energy consumption standards for polysilicon products, focusing on limiting new production capacity [3] - The Ministry of Industry and Information Technology has issued a special energy-saving inspection task list for polysilicon, which may lead to energy consumption controls on existing production capacity [3]